StockData
Insight Molecular Diagnostics Inc. logo

Insight Molecular Diagnostics Inc. (IMDX) stock

IMDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$1.59−0.19 (-10.67%)

Close on Nov 18, 2026Market cap $52.03MP/E –Yield –

Insight Molecular Diagnostics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Insight Molecular Diagnostics's operating income for the twelve months ending Jun 30, 2026 was -$50.30M. For fiscal 2025 it was -$51.12M. The highest annual figure on record is -$4.97M in fiscal 2014.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$51.12M–
FY2024Dec 31, 2024-$61.04M–
FY2023Dec 31, 2023-$25.14M–
FY2022Dec 31, 2022-$18.00M–
FY2021Dec 31, 2021-$53.73M–
FY2020Dec 31, 2020-$29.71M–
FY2019Dec 31, 2019-$22.24M–
FY2018Dec 31, 2018-$15.20M–
FY2017Dec 31, 2017-$18.85M–
FY2016Dec 31, 2016-$11.14M–
FY2015Dec 31, 2015-$8.72M–
FY2014Dec 31, 2014-$4.97M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$11.40M–
Q1 FY2026Mar 31, 2026-$4.41M–
Q4 FY2025Dec 31, 2025-$23.44M–
Q3 FY2025Sep 30, 2025-$11.05M–
Q2 FY2025Jun 30, 2025-$9.84M–
Q1 FY2025Mar 31, 2025-$6.80M–
Q4 FY2024Dec 31, 2024-$33.63M–
Q3 FY2024Sep 30, 2024-$13.52M–
Q2 FY2024Jun 30, 2024-$4.63M–
Q1 FY2024Mar 31, 2024-$9.27M-258.4%
Q4 FY2023Dec 31, 2023-$16.18M–
Q3 FY2023Sep 30, 2023-$6.51M–
Q2 FY2023Jun 30, 2023-$8.29M–
Q1 FY2023Mar 31, 2023$5.85M–
Q4 FY2022Dec 31, 2022-$11.65M–
Q3 FY2022Sep 30, 2022-$1.71M–
Q2 FY2022Jun 30, 2022-$1.63M–
Q1 FY2022Mar 31, 2022-$3.02M–
Q4 FY2021Dec 31, 2021-$35.68M–
Q3 FY2021Sep 30, 2021-$13.60M–
Q2 FY2021Jun 30, 2021-$13.57M–
Q1 FY2021Mar 31, 2021-$11.36M–
Q4 FY2020Dec 31, 2020-$6.27M–
Q3 FY2020Sep 30, 2020-$6.24M–
Q2 FY2020Jun 30, 2020-$8.77M–
Q1 FY2020Mar 31, 2020-$8.43M–
Q4 FY2019Dec 31, 2019-$7.52M–
Q3 FY2019Sep 30, 2019-$5.26M–
Q2 FY2019Jun 30, 2019-$5.46M–
Q1 FY2019Mar 31, 2019-$4.00M–
Q4 FY2018Dec 31, 2018-$4.05M–
Q3 FY2018Sep 30, 2018-$3.02M–
Q2 FY2018Jun 30, 2018-$4.23M–
Q1 FY2018Mar 31, 2018-$3.91M–
Q4 FY2017Dec 31, 2017-$3.89M–
Q3 FY2017Sep 30, 2017-$6.84M–
Q2 FY2017Jun 30, 2017-$3.59M–
Q1 FY2017Mar 31, 2017-$4.53M–
Q4 FY2016Dec 31, 2016-$3.09M–
Q3 FY2016Sep 30, 2016-$2.58M–

More Insight Molecular Diagnostics figures

See a number that looks wrong?